MoneyWorks4Me

Unjha Formulations - Quaterly Results

05 Feb 2026 Evaluate
The revenue zoomed 17.62% to Rs. 44.39 millions for the quarter ended December 2025 as compared to Rs. 37.74 millions during the corresponding quarter last year.A humble growth in net profit of 6.22% reported in the quarter ended December 2025 to Rs. 2.39  millions from Rs. 2.25 millions.Operating Profit saw a handsome growth to 2.82 millions from 2.50 millions in the quarter ended December 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 44.39 37.74 17.62 124.20 115.35 7.67 139.77 185.08 -24.48
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 2.82 2.50 12.80 15.49 8.86 74.83 6.30 5.89 6.96
Interest 0.02 0.02 0.00 0.05 0.05 0.00 0.08 0.56 -85.71
PBDT 2.80 2.48 12.90 15.44 8.81 75.26 6.22 5.33 16.70
Depreciation 0.41 0.23 78.26 0.98 0.67 46.27 0.98 0.81 20.99
PBT 2.39 2.25 6.22 14.46 8.14 77.64 5.24 4.52 15.93
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.16 1.74 -33.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.06 -116.67
PAT 2.39 2.25 6.22 14.46 8.14 77.64 4.08 2.78 46.76
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 6.35 6.62 -4.10 12.47 7.68 62.37 4.51 3.18 41.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..